Good Results with Individually Adapted Long-Term Immunosuppression Following Alemtuzumab Versus ATG Induction Therapy in Combined Kidney-Pancreas Transplantation: A Single-Center Report

DOI: 10.12659/AOT.911712

Keywords: Immunosuppressive Agents, Kidney Transplantation, Pancreas Transplantation

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text